Journals / Ulusal Cerrahi Dergisi / 2015 / Cilt: 31 - Sayı: 4

Co-existent breast and renal cancer

Meme ve böbrek kanseri: Eş zamanlı birliktelik

Pages
238–240
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Hormonotherapy for breast cancer is still continuing.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature.
📊
Key Findings & Data:A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass.
💡
Conclusion & Impact:Hormonotherapy for breast cancer is still continuing.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The concomitant presence of breast cancer with one or more other types of cancer such as colon, vulva, lung, larynx, liver, uterus and kidneys has been presented in the literature. However, synchronous breast and renal cancer is very uncommon. Herein we present a woman with synchronous breast and renal cancer, and review the literature. A 77-year-old post-menopausal woman was admitted to our clinic complaining of left sided breast mass. On physical examination, there was a 3 cm palpable mass in the upper outer quadrant of the left breast along with a conglom-erate of lymph nodes in the left axilla. Ultrasonography and mammography showed a 3 cm solid, hypoechoic mass in the upper outer quadrant and left axillary lymphadenopathy. The tru-cut biopsy of the lesion revealed invasive ductal carcinoma. The bone scintigraphy, thoracic and cranial computerized tomographies were normal. The ab-dominal computerized tomography identified a 3x3 cm solid renal mass with heterogeneous contrast enhancement in the posterior segment of the lower pole, which was suspicious for renal cell carcinoma. Breast conserving surgery and axillary lymph node dissection was performed, and the pathology specimen demonstrated invasive ductal car-cinoma. The patient was discharged on postoperative day 5. Three weeks later partial nephrectomy was performed by urology department for the solid renal mass, and the pathology result showed clear cell-renal carcinoma with Fuhrman grade 3. The patient is being followed-up for renal carcinoma, and underwent radiotherapy for breast cancer. Hormonotherapy for breast cancer is still continuing.

Özet

Meme kanserinin eş zamanlı tekli ya da çoklu olarak kolon, vulva, akciğer, larinks, karaciğer, uterus ve böbrek kanseri ile birlikteliği bildirilmiş ancak sadece böbrek ile birlikteliği literatürde oldukça nadirdir. Burada eş zamanlı meme kanseri ve renal hücreli karsinom (RHK) tanısı konan olgu literatür eşliğinde sunulmuştur. Polikliniğimize 77 yaşında postmenopozal kadın olgu sol memede kitle nedeniyle başvurdu. Fizik muayenede sol meme üst dış kadranda yaklaşık 3 cm çaplı kitle ve aksillada konglomere lenfadenopati mevcuttu. Ultrasonografi ve mamografide sol meme üst dış kadranda kitle ve aksiller lenfadenopati saptanan olgunun yapılan tru-cut biyopsisinde invaziv duktal meme karsinomu saptandı. Yapılan uzak organ metastazı taramasında kemik sintigrafisi, toraks ve beyin tomografisi olağandı. Bilgisayarlı batın tomografisinde, sol böbrek posteriorda 3 cm çaplı heterojen kontrastlanma gösteren solid kitle bulgusu izlendi ve RHK düşünüldü. Olguya meme koruyucu cerrahi + aksiller diseksiyon uygulandı. Histopatolojisi; invaziv duktal karsinom ile uyumluydu. Postoperatif 5. günde taburcu edilen olguya 3 hafta sonra parsiyel nefrektomi uygulandı. Nefrektomi histopatolojisi; berrak hücreli-böbrek hücreli karsinom (Fuhrman grad 3) şeklindeydi. Olgu renal hücreli karsinom için takip edilmekte olup meme kanseri için radyoterapi aldı. Ayrıca hormonoterapisi devam etmektedir

🔖

Cite This Article

ÜREYEN, O., DADALI, E., AKDENİZ, F., ŞAHİN, T., TEKELİ, M. T., ELİYATKIN, N. Ö., POSTACI, H., İLHAN, E. (2015). Co-existent breast and renal cancer. Ulusal Cerrahi Dergisi, Cilt: 31 - Sayı: 4, 238–240. https://ajindex.com/articles/325387

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Kurlekar UA, Rayate AS. Synchronous primary malignancies in breast and kidney: A rare case report. Indian J Surg 2014; [Epub of print]. Jiao F, Yao LJ, Zhou J, Hu H, Wang LW. Clinical features of multiple primary malignancies: a retrospective analysis of 72 Chinese pa- tients. Asian Pac J Cancer Prev 2014; 15: 331-334. [CrossRef] Kurul S, Akgun Z, Kaytan Saglam E, Basaran M, Yucel S, Tuzlali S. Successful treatment of triple primary tumor. Int J Surg Case Rep 2013; 4: 1013-1016. [CrossRef] Kalender ME, Sevinç A, Tutar E, Camcı C. Senkron renal hücreli karsinom ve meme medüller karsinom birlikteliği. UHOD 2005; 2: 90-93.
  2. Chakraborty S, Tarantolo SR, Batra SK, Hauke RJ. Incidence and prognostic significance of second primary cancers in renal cell carcinoma. Am J Clin Oncol 2013; 36: 132-142. [CrossRef] Sarma M, Borde C, Subramanyam P, Sundaram PS. Random synchronous malignancy in male breast: A case report. J Breast Cancer 2013; 16: 442-446. [CrossRef] Pastore AL, Palleschi G, Autieri D, Leto A, Ripoli A, Maggioni C, et al. Synchronous primary neoplasms of the bladder, skin and breast in a male patient: a case report. World J Surg Oncol 2013, 11: 282. [CrossRef] Brunicardi FC, Andersen DK, Billiar TR, Dunn DL, Hunter JG, Matt- hews JB, et al. Schwartz's Principles of Surgery. 9th ed. New York: Mc Graw- Hill professional; 2009.
  3. Lang H, Jacqmin D. Prognostic factors in renal cell carcinoma. EAU Update Series 2003; 1: 215-219. [CrossRef] Koutsopoulos AV, Dambaki KI, Datseris G, Giannikaki E, Froudara- kis M, Stathopoulos E. A novel combination of multiple primary carcinomas: Urinary bladder transitional cell carcinoma, pros- tate adenocarcinoma and small cell lung carcinoma-report of a case and review of the literature. World J Surg Oncol 2005; 3: 51. [CrossRef] 240